Clinical trial
The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles
NCT03659864 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles
- Lead sponsor
- University of Edinburgh
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 3, 2018
- Completion date
- November 27, 2020
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood biomarkers, blood clotting, healthy volunteers, lung function, vasodilation